Rafferty Asset Management, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$13.58 - $17.36 $1.07 Million - $1.37 Million	78,655 Added 56.35%	218,237 $3.43 Million
Q4 2023 Feb 13, 2024	SELL	$10.11 - $16.54 $1,597 - $2,613	-158 Reduced 0.11%	139,582 $2.25 Million
Q3 2023 Nov 13, 2023	SELL	$12.46 - $15.48 $1.14 Million - $1.41 Million	-91,351 Reduced 39.53%	139,740 $1.78 Million
Q2 2023 Aug 11, 2023	SELL	$13.28 - $15.96 $38,790 - $46,619	-2,921 Reduced 1.25%	231,091 $3.25 Million
Q1 2023 May 11, 2023	SELL	$14.26 - $22.1 $265,392 - $411,303	-18,611 Reduced 7.37%	234,012 $3.62 Million
Q4 2022 Feb 13, 2023	BUY	$14.85 - $19.04 $750,964 - $962,852	50,570 Added 25.03%	252,623 $4.14 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $562,881 - $919,797	45,467 Added 29.04%	202,053 $3.74 Million
Q2 2022 Aug 12, 2022	SELL	$9.11 - $13.98 $2.42 Million - $3.72 Million	-265,801 Reduced 62.93%	156,586 $2.06 Million
Q1 2022 May 13, 2022	SELL	$6.87 - $11.11 $862,940 - $1.4 Million	-125,610 Reduced 22.92%	422,387 $3.92 Million
Q4 2021 Feb 10, 2022	BUY	$7.7 - $37.13 $3.71 Million - $17.9 Million	482,080 Added 731.34%	547,997 $5.35 Million
Q3 2021 Nov 10, 2021	SELL	$26.46 - $37.15 $204,562 - $287,206	-7,731 Reduced 10.5%	65,917 $2.24 Million
Q2 2021 Aug 10, 2021	SELL	$32.73 - $47.95 $118,318 - $173,339	-3,615 Reduced 4.68%	73,648 $2.7 Million
Q1 2021 May 10, 2021	BUY	$40.39 - $56.73 $2.46 Million - $3.45 Million	60,902 Added 372.24%	77,263 $3.46 Million
Q4 2020 Feb 10, 2021	SELL	$51.77 - $66.18 $1.36 Million - $1.74 Million	-26,269 Reduced 61.62%	16,361 $934,000
Q3 2020 Nov 13, 2020	BUY	$43.8 - $58.16 $1.1 Million - $1.45 Million	25,012 Added 141.97%	42,630 $2.19 Million
Q2 2020 Aug 07, 2020	BUY	$37.05 - $65.03 $652,746 - $1.15 Million	17,618 New	17,618 $1.05 Million
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $1.12 Million - $2.32 Million	-33,415 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$31.7 - $69.93 $203,926 - $449,859	-6,433 Reduced 16.14%	33,415 $2.08 Million
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $185,395 - $361,033	9,293 Added 30.41%	39,848 $1.35 Million
Q2 2019 Aug 09, 2019	SELL	$21.05 - $26.21 $52,140 - $64,922	-2,477 Reduced 7.5%	30,555 $689,000
Q1 2019 May 15, 2019	BUY	$20.65 - $29.55 $682,110 - $976,095	33,032 New	33,032 $767,000

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account